Tag Archives: BRCA DNA

Can AMP v. Myriad Revive Diagnostic Method Claims?

Posted on June 17, 2013 by Warren Woessner

At the end of the Supreme Court’s Opinion, Justice Thomas makes it clear that the Court was impressed by Judge Byson’s dissents in the Fed. Cir. Myriad opinions. Although Judge Bryson was on the Intema panel that sank claims to … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged AMP v. Myriad, BRCA DNA, Federal Circuit, Patent Law, Supreme Court, Warren Woessner | 4 Comments

AMP Petitions for Cert. and A Look Back

Posted on December 16, 2011 by Warren Woessner

The Association for Molecular Pathology (AMP) has petitioned the Supreme Court to review the Fed. Cir.’s opinion of July 29th, that isolated BRCA DNA sequences are patentable subject matter. Its brief (a copy available at the end of this post) … Continue reading →